Lucintel Forecasts the Global Biopsy Device Market to Reach $3.7 billion by 2030.

Biopsy Device Market

CITY, Country, 2023-Nov-21 — /EPR Network/ —

According to a market report by Lucintel, the future of the global biopsy device market looks promising with opportunities in the breast biopsy, lung biopsy, colorectal biopsy, and prostate biopsy markets. The global biopsy device market is expected to reach an estimated $3.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and increasing demand for minimally invasive procedures.

A more than 150 – page report is developed to understand Trends, opportunity and forecast in biopsy device market to 2030 by product (needle-based biopsy devices, localization wires, procedure trays, and others), guidance technique (ultrasound-guided biopsy, stereotactic-guided biopsy, MRI-guided biopsy, and others), application (breast biopsy, lung biopsy, colorectal biopsy, prostate biopsy, and others), end use (hospitals, academic and research institutes, and diagnostic and imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).

In this market, needle based biopsy instrument, liquid biopsy instrument, localization wire, biopsy forcep, procedure tray, and biopsy table are the major segments of biopsy device market by product. Lucintel forecasts that needle-based biopsy instrument is expected to witness the highest growth over the forecast period.

Within this market, breast biopsy is expected to witness the highest growth over the forecast period.

North America is expected to witness highest growth over the forecast period.

Cook Medical, Boston Scientific, Fujifilm, Cardinal Health, and Danaher are the major suppliers in the biopsy device market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. 972.636.5056

Explore Our Latest Publications

Botnet Detection Market

Radar Level Transmitter Market

RAID Controller Card Market

Self-Healing Grid Market

Colonoscopy Device Market

Molded Interconnect Device (MID) Market

 

Matched content

Editor’s pick

Express Press Release Distribution